Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 19422452)

1.

Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.

Diener JL, Daniel Lagassé HA, Duerschmied D, Merhi Y, Tanguay JF, Hutabarat R, Gilbert J, Wagner DD, Schaub R.

J Thromb Haemost. 2009 Jul;7(7):1155-62. doi: 10.1111/j.1538-7836.2009.03459.x. Epub 2009 Apr 24.

PMID:
19422452
2.

Targeting von Willebrand factor and platelet glycoprotein Ib receptor.

Firbas C, Siller-Matula JM, Jilma B.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1689-701. doi: 10.1586/erc.10.154. Review.

PMID:
21108551
3.

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.

Spiel AO, Mayr FB, Ladani N, Wagner PG, Schaub RG, Gilbert JC, Jilma B.

Platelets. 2009 Aug;20(5):334-40. doi: 10.1080/09537100903085927.

PMID:
19637097
4.

The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.

Mayr FB, Knöbl P, Jilma B, Siller-Matula JM, Wagner PG, Schaub RG, Gilbert JC, Jilma-Stohlawetz P.

Transfusion. 2010 May;50(5):1079-87. doi: 10.1111/j.1537-2995.2009.02554.x. Epub 2010 Jan 8.

PMID:
20070617
5.

Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.

Bae ON.

Arch Pharm Res. 2012 Oct;35(10):1693-9. doi: 10.1007/s12272-012-1000-3. Review.

PMID:
23139119
6.

ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesion.

Siller-Matula JM, Merhi Y, Tanguay JF, Duerschmied D, Wagner DD, McGinness KE, Pendergrast PS, Chung JK, Tian X, Schaub RG, Jilma B.

Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):902-9. doi: 10.1161/ATVBAHA.111.237529. Epub 2012 Jan 26.

7.

Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.

Hoylaerts MF.

Verh K Acad Geneeskd Belg. 1997;59(3):161-83. Review.

PMID:
9490916
8.

An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.

Arzamendi D, Dandachli F, Théorêt JF, Ducrocq G, Chan M, Mourad W, Gilbert JC, Schaub RG, Tanguay JF, Merhi Y.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E70-8. doi: 10.1177/1076029610384114. Epub 2010 Nov 15.

PMID:
21078615
9.

Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.

Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV.

Blood. 1993 Mar 1;81(5):1263-76.

10.

A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.

Jilma B, Paulinska P, Jilma-Stohlawetz P, Gilbert JC, Hutabarat R, Knöbl P.

Thromb Haemost. 2010 Sep;104(3):563-70. doi: 10.1160/TH10-01-0027. Epub 2010 Jun 29.

PMID:
20589313
11.

Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V.

Gresele P, Momi S.

Handb Exp Pharmacol. 2012;(210):287-309. doi: 10.1007/978-3-642-29423-5_12. Review.

PMID:
22918736
12.

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers.

Gilbert JC, DeFeo-Fraulini T, Hutabarat RM, Horvath CJ, Merlino PG, Marsh HN, Healy JM, Boufakhreddine S, Holohan TV, Schaub RG.

Circulation. 2007 Dec 4;116(23):2678-86. Epub 2007 Nov 19.

14.

Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.

Matsui T, Hamako J, Matsushita T, Nakayama T, Fujimura Y, Titani K.

Biochemistry. 2002 Jun 25;41(25):7939-46.

PMID:
12069583
15.

The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.

Jilma-Stohlawetz P, Knöbl P, Gilbert JC, Jilma B.

Thromb Haemost. 2012 Aug;108(2):284-90. doi: 10.1160/TH11-12-0889. Epub 2012 Jun 28.

PMID:
22740102
16.
17.
18.

Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.

Sixma JJ, Ijsseldijk MJ, Hindriks G, van Zanten GH, Gorecki M, Panet A, Garfinkel LI, de Groot PG.

Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):64-71.

19.

Function of von Willebrand factor in haemostasis and thrombosis.

Reininger AJ.

Haemophilia. 2008 Nov;14 Suppl 5:11-26. doi: 10.1111/j.1365-2516.2008.01848.x. Review.

PMID:
18786007
20.

Structure and function of snake venom toxins interacting with human von Willebrand factor.

Matsui T, Hamako J.

Toxicon. 2005 Jun 15;45(8):1075-87. Epub 2005 Apr 22. Review.

PMID:
15922776
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk